Diabetes complications

High-density lipoprotein cholesterol and kidney disease progression in patients with type 2 diabetes mellitus: the Fukushima Cohort Study

BMJ Open Diabetes Res CarePublished Prospective cohort study

Main finding · Kidney eventsResult — go to the resultAdjusted hazard ratio 2.61 95% CI 1.32–5.14

Authors' conclusion

Low HDL-C levels were independently associated with kidney events and all-cause mortality in patients with T2DM. Future studies are warranted to clarify whether interventions targeting HDL-C can improve kidney disease progression in this high-risk population.

Study context

Population
Patients with T2D from the Fukushima Cohort Study; median age 66 years, 56% men, median estimated glomerular filtration rate (eGFR) 68.6 mL/min/1.73 m²
Participants
1,033 patients
Exposure
Lowest high-density lipoprotein cholesterol (HDL-C) quartile vs reference HDL-C quartile
Outcome
Kidney events: ≥50% decrease in eGFR or kidney failure requiring kidney replacement therapy
Follow-up
Median 5.3 years
Methodological detailsCox proportional hazards models, multivariable adjusted, lipid parameters in quartiles
  • Cox proportional hazards models
  • Multivariable adjusted
  • Lipid parameters in quartiles

Main finding

Kidney events

Adjusted hazard ratio

2.61

95% CI 1.32–5.14

HDL-C <42 mg/dLvs HDL-C 49-58 mg/dL
aHR 2.61 (95% CI 1.32–5.14)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)
All-cause mortality2.27 (1.16–4.42)

All-cause mortality

U-shaped association between HDL-C and all-cause mortality

Other lipid parameters (triglycerides (TG), LDL-C, non-HDL-C, TG/HDL-C ratio)

No significant associations with kidney events or mortality

Subgroup and sensitivity analyses

Consistent

Original publication

High-density lipoprotein cholesterol and kidney disease progression in patients with type 2 diabetes mellitus: the Fukushima Cohort Study. BMJ Open Diabetes Res Care. Published 3 December 2025. doi:10.1136/bmjdrc-2025-005581

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.